The investment partnership «Live Systems Seed Fund» founded in 2015 by KSI Ventures and RVC Seed Investments Fund, has invested in the Brain Bit project that develops non-invasive glucose meter based on the own patented technology of bloodless spectroscopy measurement of the blood sugar level.
Bayer, a German-headquartered pharmaceutical multinational, has picked three most promising Russian IT start-ups out of 150 focused on biomed to bring them into its Moscow-based acceleration program in partnership with Russia’s Internet Initiatives Development Fund (FRII in Russian) Accelerator.
The Skolkovo Foundation’s biomedicine cluster is to study the creation of a genetics centre that would guarantee Russia’s agricultural independence, after the foundation’s council approved the plan’s development.
Two Russian businessmen — former Qiwi shareholder and Parus Capital President Andrey Muravyev and Parus Capital Managing Partner Boris Sinegubko — invested last year “several million US dollars” in three Iranian Internet companies.
Fungipak, a Russian biotech developer and resident of the Skolkovo innovation hub just outside Moscow, is working on a brand new form of bioactive agents to protect crops against pests, especially locusts.